misoprostol

Washington — The Food and Drug Administration says its ongoing safety review of the nation’s main abortion pill will continue into next year, a timeline that was quickly condemned by abortion rights opponents hoping to see the drug’s use curtailed. The FDA gave a court-ordered update on its progress in a legal filing late Wednesday,…